Evidence map›Paper›PMID 30779754›Full record

ArticlePloS one2019

C4-HSL aptamers for blocking qurom sensing and inhibiting biofilm formation in Pseudomonas aeruginosa and its structure prediction and analysis.

Meng Zhao, Weibin Li, Kuancan Liu, Huiling Li, Xiaopeng Lan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Aptamers: precision tools for diagnosing and treating infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  5. Review
  6. Review
  7. Methods and Applications of In Silico Aptamer Design and Modeling.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meng ZhaoSecond Military Medical University, Shanghai, China.ORCID 0000-0001-5067-129X
Weibin LiInstitute for Laboratory Medicine, The 900th Hospital of Joint Service Support Force, Fuzhou, Fujian, China.
Kuancan LiuInstitute for Laboratory Medicine, The 900th Hospital of Joint Service Support Force, Fuzhou, Fujian, China.
Huiling LiInstitute for Laboratory Medicine, The 900th Hospital of Joint Service Support Force, Fuzhou, Fujian, China.
Xiaopeng LanSecond Military Medical University, Shanghai, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to screen DNA aptamers against the signal molecule C4-HSL of the rhl system for the inhibition of biofilm formation of Pseudomonas aeruginosa using an improved systematic evolution of ligand by exponential enrichment (SELEX) method based on a structure-switching fluorescent activating bead. The aptamers against the C4-HSL with a high affinity and specifity were successfully obtained and evaluated in real-time by this method. Results of biofilm inhibition experiments in vitro showed that the biofilm formation of P. aeruginosa was efficiently reduced to about 1/3 by the aptamers compared with that of the groups without the aptamers. Independent secondary structure simulation and computer-aided tertiary structure prediction (3dRNA) showed that the aptamers contained a highly conserved Y-shaped structural unit. Therefore, this study benefits the search for new methods for the detection and treatment of P. aeruginosa biofilm formation.

Indexed as

4-ButyrolactoneAptamers, NucleotideBacterial ProteinsBiofilmsDrug DesignModels, MolecularNucleic Acid ConformationProtein BindingPseudomonas aeruginosaQuorum SensingStructure-Activity Relationship4-ButyrolactoneAptamers, NucleotideBacterial ProteinsN-butyrylhomoserine lactoneRhlR protein, Pseudomonas aeruginosa

Identifiers

PMID30779754
PMCPMC6380626
OpenAlexW2915207412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.